Depression in Chronic Airways Diseases

Chronic Lung Disease Clinical Trial

Official title:

Anxiety and Depression in Chronic Airways Diseases

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03180164
• Other study ID #: CLD
• Status: Not yet recruiting
• Phase: N/A
• First received: June 6, 2017
• Last updated: January 8, 2018
• Start date: October 2018
• Est. completion date: October 2019

Study information

• Verified date: January 2018
• Source: Assiut University
• Contact: Maha Ahmed El-Kholy
• Phone: 00201096956205
• Email: maha_elkholy[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Chronic airways diseases involve alterations in the person's social roles, relationships and self-perception so demands continual psychological adjustment .

Also Kunik studied patients with chronic breathing disorders for depression and anxiety and found that 65% of patients were positive for depression and anxiety.

Shackell found that patients' anxiety and fears of breathlessness and dying extended into the night and were aggravated by feelings of isolation and frustration. One patient reported that they often thought 'am I going to see the next morning?'

Description:

This fear and sense of helplessness can lead to panic and evidence suggests that patients with chronic breathlessness often call for emergency assistance during the night According to GOLD report 2017, anxiety and depression in chronic obstructive pulmonary disease patients are both associated with poor prognosis.

Much of the evidence explored so far relates to chronic obstructive pulmonary disease. While other chronic lung diseases have received less attention In addition to, several studies have been found relationship between asthma and psychological disturbance .One review of literature describes an increased prevalence of psychological co-morbidity in asthmatic adults and another research suggests that anxiety and depression are more common in patients with moderate to severe asthma than in the general population Gift. found significantly greater self-reported depression scores among patients with chronic obstructive pulmonary disease receiving prednisone compared to patients not receiving any steroids.

Interestingly, the psychiatric sequel of steroid treatment are often sudden in onset and appear to generally occur within 2 weeks after steroid introduction

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 1
• Est. completion date: October 2019
• Est. primary completion date: October 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Chronic airways diseases as chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis

Exclusion Criteria:

• Diabetes Mellitus and Hypertension.

• Cardiac diseases.

• Chronic renal and liver diseases.

Related Conditions & MeSH terms

• Chronic Lung Disease
• Depression
• Lung Diseases
• Pulmonary Disease, Chronic Obstructive

Intervention

Other:
• hospital anxiety and depression scale
self-assessment scale has been developed and found to be a reliable instrument for detecting states of depression and anxiety in the setting of an hospital medical outpatient clinic

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	compare anxiety and depression in different forms of chronic lung diseases	by hospital anxiety and depression scale	10 minutes